针对脑瘤的抗体结合纳米启用药物输送系统
Beril Taş Topçu1, Sibel Bozdağ Pehlivan1, Yagmur Akdağ1
1Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University 06100, Ankara, Turkey.
Journal of pharmaceutical sciences
|March 31, 2024
概括
抗体结合纳米颗粒通过向癌细胞和穿越血脑屏障 (BBB) 来治疗脑瘤有希望. 这种方法提高了药物输送,为有效的脑癌疗法提供了新的希望.
科学领域:
- 纳米技术纳米技术
- 在瘤学瘤学.
- 神经科学是一个神经科学.
背景情况:
- 脑瘤治疗面临的挑战是由于血脑屏障 (BBB).
- 抗体结合纳米粒子为向药物输送提供了一种新的策略.
- 抗转林受体抗体增强了大脑内皮细胞中纳米颗粒的吸收.
研究的目的:
- 探索抗体结合纳米颗粒在脑瘤治疗中的潜力.
- 评估纳米颗粒准和交付在整个BBB.
- 评估纳米粒子介导药物输送系统对脑癌的疗效.
主要方法:
- 纳米粒子与抗转林受体抗体的功能化.
- 研究大脑毛细体内皮细胞对纳米颗粒的吸收.
- 评估药物和抗体对脑瘤和转移的向输送.
- 通过对流增强交付评估纳米粒子分布.
主要成果:
- 抗体结合纳米颗粒显示大脑内皮细胞的吸收增强.
- 观察到纳米颗粒与大脑癌细胞的特定结合.
- 向的纳米颗粒显示出转细胞化BBB的潜力,以提供治疗药物.
- 纳米粒子传递系统的进步提高了脑癌治疗的疗效.
结论:
- 抗体结合纳米粒子代表了对脑瘤的有希望的治疗策略.
- 这些纳米粒子可以克服BBB挑战,改善药物输送.
- 有针对性的纳米粒子方法正在推进有效的脑癌治疗方法.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...